Core Insights - Daxor Corporation has launched the ezBVA Lab program in partnership with a leading 1,000+ bed comprehensive medical center in western Florida to enhance blood volume analysis capabilities [1][2] - The ezBVA Lab service offers rapid 24-hour testing, aimed at optimizing heart failure treatment outcomes and reducing associated costs [1][2] - Daxor's BVA diagnostic provides 98% accurate data for individualized fluid management, which is crucial for improving patient outcomes in heart failure care [3] Company Overview - Daxor Corporation is recognized as the global leader in blood volume measurement technology, with the BVA-100™ being the only FDA-cleared diagnostic blood test for quantifying blood volume status [4] - Over 65,000 tests have been conducted at leading hospitals in the U.S., significantly reducing mortality and readmissions in heart failure and critical care [4] - The company is engaged in ongoing trials for heart failure treatment supported by the NIH and is developing analyzers for combat casualty care in collaboration with the U.S. Department of Defense [4]
Leading Central Florida Hospital Implements Daxor's BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care